about
Imaging Modalities to Assess Oxygen Status in GlioblastomaIschaemic brain damage induced by rapid lowering of arterial pressure in hypertension.Effects of hemorrhagic hypotension on the cerebral circulation. I. Cerebral blood flow and pial arteriolar caliber.Proceedings: Autoregulation of cerebral blood flow in chronically hypertensive baboons.Selective blockade of endothelin-B receptors exacerbates ischemic brain damage in the rat.The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling.Intraluminal thread model of focal stroke in the non-human primate.Effects of urotensin-II on cerebral blood flow and ischemia in anesthetized rats.Transforming growth factor-beta and ischemic brain injury.Heterogeneous vasomotor responses of anatomically distinct feline cerebral arteries.Detection of glioblastoma response to temozolomide combined with bevacizumab based on μMRI and μPET imaging reveals [18F]-fluoro-L-thymidine as an early and robust predictive marker for treatment efficacy.Hypoxia induces macrophage polarization and re-education toward an M2 phenotype in U87 and U251 glioblastoma modelsAngiopoietin-2 is vasoprotective in the acute phase of cerebral ischemiaMultimodal imaging based on MRI and PET reveals [(18)F]FLT PET as a specific and early indicator of treatment efficacy in a preclinical model of recurrent glioblastoma.Noninvasive assessment of hypoxia with 3-[18F]-fluoro-1-(2-nitro-1-imidazolyl)-2-propanol ([18F]-FMISO): a PET study in two experimental models of human glioma.The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age.Cerebral circulatory and metabolic effects of perivascular neurotransmitters.Arginine 260 of the amino-terminal domain of NR1 subunit is critical for tissue-type plasminogen activator-mediated enhancement of N-methyl-D-aspartate receptor signaling.Sp1 and Smad transcription factors co-operate to mediate TGF-beta-dependent activation of amyloid-beta precursor protein gene transcription.Is tissue-type plasminogen activator a neuromodulator?Neuroprotection mediated by glial cell line-derived neurotrophic factor: involvement of a reduction of NMDA-induced calcium influx by the mitogen-activated protein kinase pathway.Cholinergic and vasoactive intestinal polypeptidergic innervation of the cerebral arteries.Cerebral circulation and norepinephrine: relevance of the blood-brain barrier.Regional cerebral blood flow responses to neurochemical stimulation of the substantia innominata in the anaesthetized rat.Cerebrovascular nerve fibers immunoreactive for tryptophan-5-hydroxylase in the rat: distribution, putative origin and comparison with sympathetic noradrenergic nerves.A potential role for erythropoietin in focal permanent cerebral ischemia in mice.Calcium antagonists: effects on cerebral blood flow and blood-brain barrier permeability in the rat.Inhibition of neuronal nitric oxide synthase by 7-methoxyindazole and related substituted indazoles.Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity.Smad3-dependent induction of plasminogen activator inhibitor-1 in astrocytes mediates neuroprotective activity of transforming growth factor-beta 1 against NMDA-induced necrosis.Angiopoietin-1-induced PI3-kinase activation prevents neuronal apoptosis.Potential use of early alterations in mu and delta opioid receptors as a predictive index for delayed brain ischemic damage.Differential time-course decreases in nonselective, mu-, delta-, and kappa-opioid receptors after focal cerebral ischemia in mice.Reduction of ischemic brain damage by nitrous oxide and xenon.2,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo.Cerebrovascular effects of sodium nitroprusside in the anaesthetized baboon: a positron emission tomographic study.Akt-dependent expression of NAIP-1 protects neurons against amyloid-{beta} toxicity.Tissue-type plasminogen activator crosses the intact blood-brain barrier by low-density lipoprotein receptor-related protein-mediated transcytosis.Postischemic nitrous oxide alone versus intraischemic nitrous oxide in the presence of isoflurane: what it may change for neuroprotection against cerebral stroke in the rat.NMDA receptor activation inhibits alpha-secretase and promotes neuronal amyloid-beta production.
P50
Q26782708-3E3C281E-4299-4112-82B2-8FDD85CD619FQ30011318-761FC657-AF5A-4D9B-9E2B-F42CF0174B7BQ30011349-FD8400AE-3687-4591-8433-7A8A9F8312A5Q30011380-D8CEF175-D620-4574-9B6A-9B0864A5D296Q31120381-1DC285A7-619E-4E08-BD36-4739647FEB07Q31793818-A891886A-8BF5-4537-A704-F98F49BD1394Q33305426-0C5B891E-4640-40C2-9DDA-285C4B4165ECQ33314499-21B094E9-83A1-4511-8F5B-73A3FB035CBAQ35545534-E8A59562-8EEB-44B9-8BF3-1799EF8FFFC3Q35755546-8D8FECBF-CC14-47DB-B885-32EAA2714D5FQ36500372-637958CD-511A-4412-8463-502D42673772Q36597491-C3F5C867-2CE3-4B9C-AC5E-EBC90DD121E8Q36655378-ABBE749E-1840-41B1-96B8-FC36BED3EFD3Q38822001-FBEE2647-E3B3-47CB-AE0A-663875502EECQ39469151-D7B9766F-D92B-4AB0-9D4F-65FFC505C838Q39486551-8E1E7F12-7736-4654-9893-F22256954467Q39658358-F240EA43-C8CA-4F5C-BBA1-0D3CA270516DQ40511087-03CDB4E8-3459-44F8-9336-55C98D2E4540Q40537891-12A2F009-DEEC-4E0D-833C-A372DC0EC0C2Q40567601-C096C5A7-AB08-414D-AA90-CF164F01A6A2Q40811557-3407AF25-DD0E-4879-AD29-E95C88E3D3E3Q40955484-2799FA8D-F410-4F4C-B1AF-F4D479319B9FQ41060549-4C880395-C35B-4998-BB7C-76865E77CFF4Q41680350-779B1CAD-9A3F-49C2-A4C9-D905942297C2Q42457987-7DA25958-B45A-4D27-BE43-6C2D33930347Q42473313-A1D1E093-D000-4FA2-B935-B59A97343BCEQ42635509-5B122C06-BA95-4914-8AC3-5E5A5E142175Q43608729-72C2DFE8-63B6-4668-BF83-F893950A1FCEQ44254892-79B2539E-9A43-4E9B-86FB-0ED6CAC54466Q44264175-81B58522-09E5-4E6A-A22B-9B3984DA0541Q44270070-419687DE-0286-4CFD-8422-2C44E2A5838FQ44341626-9121A7A6-C21A-4416-8C0B-A0015DAF4B8EQ44352154-500BBB04-5FF5-40C0-99FE-970789AE5C15Q44606739-381BAB83-4257-4296-BEC9-185F7C74A245Q45141104-9FA3508B-05CE-427C-9DD1-37DE43A2BC93Q45259626-5E330F45-549B-4991-9B64-9E835E4987D0Q46410696-B8A32F0B-F356-404D-91A9-6165947B5B01Q46455334-81A993CA-FF06-4501-864A-558F7400B483Q46613051-C703F964-6373-497F-B137-99EC10D8F390Q46750110-D464ECD7-5743-4A1B-B6FE-5DD0E5E24AB8
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Eric T MacKenzie
@ast
Eric T MacKenzie
@en
Eric T MacKenzie
@es
Eric T MacKenzie
@nl
Eric T MacKenzie
@sl
type
label
Eric T MacKenzie
@ast
Eric T MacKenzie
@en
Eric T MacKenzie
@es
Eric T MacKenzie
@nl
Eric T MacKenzie
@sl
prefLabel
Eric T MacKenzie
@ast
Eric T MacKenzie
@en
Eric T MacKenzie
@es
Eric T MacKenzie
@nl
Eric T MacKenzie
@sl
P1006
P214
P244
P1006
P106
P21
P213
0000 0001 1655 2115
P214
P244
P31
P496
0000-0003-1057-7033
P735
P7859
lccn-n84024250